Реместип®

Active substance: terlipressin

раствор для внутривенного введения, 0.1 мг/мл, 10 мл (original in Russian, GRLS)

RussiaActive

Marketing holder: Ферринг-Лечива а.с.

Verified 2026-10-09 · GRLS (Russian state register)

Analogues in other countries

Source: GRLS (Russian state register)
Countries with the substance registered: 2

Composition

Терлипрессин

Analogues by country

Products with the same active substance registered in other countries.

Country	Products
US 1	Terlivaz INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · TERLIPRESSIN .85 mg/5mL 43825-200 Mallinckrodt Hospital Products Inc.

Import and control

Control by country

Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-548c-74a8-bd91-7cddb59c1899,01a120c4-2fcb-7bf7-a09b-3b1ad678bddd;count=2 · valid from 2026-10-09 · verified 2026-10-09
United Statesprescription only
Source: openFDA NDC · record 01a1208f-b207-7a8a-9b48-f6ac61af6356;count=1 · valid from 2026-10-09 · verified 2026-10-09

More on control status

Registration

Registration number: П N013886/01
Registration status: Active
Dispensing: Prescription only
Release forms: раствор для внутривенного введения, 0.1 мг/мл, 10 мл - ампулы (5 шт.) - пачки картонные - По рецепту; show all (2)
раствор для внутривенного введения, 0.1 мг/мл, 10 мл - ампулы (5 шт.) - пачки картонные - По рецепту; раствор для внутривенного введения, 0.1 мг/мл, 2 мл - ампулы (5 шт.) - пачки картонные - По рецепту;
(original in Russian, GRLS)

Sources

product · GRLS (Russian state register) · П N013886/01 · Verified 2026-10-09
registration_status · GRLS (Russian state register) · П N013886/01 · Verified 2026-10-09
ingredients.0 · GRLS (Russian state register) · П N013886/01 · Verified 2026-10-09